Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 46 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver diseaseEbrahimkhani, M.; Oakley, F.; Murphy, L.; Mann, J.; Moles, A.; Perugorria, M.; Ellis, E.; Lakey, A.; Burt, A.; Douglass, A.; Wright, M.; White, S.; Jaffre, F.; Maroteaux, L.; Mann, D.
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2015The therapeutic potential of interleukin-10 in neuroimmune diseasesKwilasz, A.J.; Grace, P.M.; Serbedzija, P.; Maier, S.F.; Watkins, L.R.
2014Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networksLing, K.; Hewitt, C.; Tan, K.; Cheah, P.; Vidyadaran, S.; Lai, M.; Lee, H.; Simpson, K.; Hyde, L.; Pritchard, M.; Smyth, G.; Thomas, T.; Scott, H.
2017Loss of Usp9x disrupts cell adhesion, and components of the Wnt and Notch signaling pathways in neural progenitorsPremarathne, S.; Murtaza, M.; Matigian, N.; Jolly, L.; Wood, S.
2011Actomyosin contractililty: force power drives tumor growthSamuel, M.S.; Olson, M.F.
2011Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminusMoore, N.; Weigel, N.
2014Leptin mediates the increase in blood pressure associated with obesitySimonds, S.; Pryor, J.; Ravussin, E.; Greenway, F.; Dileone, R.; Allen, A.; Bassi, J.; Elmquist, J.; Keogh, J.; Henning, E.; Myers, M.; Licinio, J.; Brown, R.; Enriori, P.; O’Rahilly, S.; Sternson, S.; Grove, K.; Spanswick, D.; Farooqi, I.; Cowley, M.
2014Androgen signalling and steroid receptor crosstalk in endocrine cancersClaessens, F.; Tilley, W.
2013Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic painWang, X.; Grace, P.; Pham, M.; Cheng, K.; Strand, K.; Smith, C.; Li, J.; Watkins, L.; Yin, H.